These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9701417)

  • 1. Relationship between cholinergic airway tone and serum immunoglobulin E in human subjects.
    Endoh N; Ichinose M; Takahashi T; Miura M; Kageyama N; Mashito Y; Sugiura H; Ikeda K; Takasaka T; Shirato K
    Eur Respir J; 1998 Jul; 12(1):71-4. PubMed ID: 9701417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis: a randomized, double blind, placebo-controlled study.
    Li J; Luo DF; Li SY; Sun BQ; Zhong NS
    Chin Med J (Engl); 2005 Oct; 118(19):1595-603. PubMed ID: 16232343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection.
    Kanazawa H; Hirata K; Yoshikawa J
    Chest; 2004 Apr; 125(4):1368-71. PubMed ID: 15078747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluating total serum IgE levels and peripheral eosinophil count in asthma and rhinitis].
    Takahashi A; Konno S; Isada A; Hattori T; Shimizu K; Shimizu K; Taniguchi N; Takahashi D; Taniguchi M; Akazawa A; Hizawa N; Nishimura M
    Arerugi; 2010 May; 59(5):536-44. PubMed ID: 20502102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
    Fujimura M; Kamio Y; Matsuda T; Hashimoto T
    Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I; Van Schil L; Van der Veken J
    Eur J Clin Pharmacol; 1994; 46(4):305-7. PubMed ID: 7957513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
    Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
    Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the IL-12B promoter polymorphism and allergic rhinitis, familial asthma, serum total IgE, and eosinophil level in asthma patients.
    Tug E; Ozbey U; Tug T; Yuce H
    J Investig Allergol Clin Immunol; 2009; 19(1):21-6. PubMed ID: 19274925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the anticholinergic agent oxitropium bromide in elderly patients with bronchial asthma.
    Shioya T; Kagaya M; Onodera A; Miura S; Shindo T; Sano M; Sasaki M; Miura M
    Arzneimittelforschung; 1996 Dec; 46(12):1130-3. PubMed ID: 9006786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxitropium bromide: an acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis.
    Bryant DH; Rogers P
    Pulm Pharmacol; 1990; 3(2):55-8. PubMed ID: 2135210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Konno S; Makita H; Suzuki M; Shimizu K; Kimura H; Kimura H; Nishimura M;
    Respir Med; 2017 Jun; 127():14-20. PubMed ID: 28502414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
    Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of nocturnal asthma by an inhaled anticholinergic drug.
    Coe CI; Barnes PJ
    Chest; 1986 Oct; 90(4):485-8. PubMed ID: 3530643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose response study of oxitropium bromide in chronic bronchitis.
    Peel ET; Anderson G
    Thorax; 1984 Jun; 39(6):453-6. PubMed ID: 6463915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
    Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
    Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma.
    Sánchez-Guerrero I; Albaladejo MD; García-Alonso AM; Muro M; Hernández J; Alvarez MR
    Allergy; 1994 Sep; 49(8):587-92. PubMed ID: 7653734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.